{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:20:02Z","timestamp":1791429602035,"version":"4.3.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T00:00:00Z","timestamp":1427241600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00213-015-3915-0","type":"journal-article","created":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T03:19:15Z","timestamp":1427167155000},"page":"2723-2729","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":130,"title":["Further human evidence for striatal dopamine release induced by administration of \u22069-tetrahydrocannabinol (THC): selectivity to limbic striatum"],"prefix":"10.1007","volume":"232","author":[{"given":"Matthijs G.","family":"Bossong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitul A.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart N. M.","family":"van Berckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver D.","family":"Howes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 S.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R. A.","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,25]]},"reference":[{"key":"3915_CR1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0031-6997(25)06861-9","volume":"38","author":"S Agurell","year":"1986","unstructured":"Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillespie H, Hollister L (1986) Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev 38:21\u201343","journal-title":"Pharmacol Rev"},{"key":"3915_CR2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1192\/bjp.184.2.110","volume":"184","author":"L Arseneault","year":"2004","unstructured":"Arseneault L, Cannon M, Witton J, Murray RM (2004) Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 184:110\u2013117","journal-title":"Br J Psychiatry"},{"key":"3915_CR3","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1177\/0269881110382465","volume":"25","author":"E Barkus","year":"2011","unstructured":"Barkus E, Morrison PD, Vuletic D, Dickson J, Ell PJ, Pilowsky LS, Brenneisen R, Holt DW, Powell J, Kapur S, Murray RM (2011) Does intravenous delta9-tetrahydrocannabinol increase dopamine release? A SPET study. J Psychopharmacol 25:1462\u20131468","journal-title":"J Psychopharmacol"},{"key":"3915_CR4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.biopsych.2013.05.027","volume":"75","author":"MA Bloomfield","year":"2014","unstructured":"Bloomfield MA, Morgan CJ, Egerton A, Kapur S, Curran HV, Howes OD (2014) Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms. Biol Psychiatry 75:470\u2013478","journal-title":"Biol Psychiatry"},{"key":"3915_CR5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/syn.10226","volume":"49","author":"I Boileau","year":"2003","unstructured":"Boileau I, Assaad JM, Pihl RO, Benkelfat C, Leyton M, Diksic M, Tremblay RE, Dagher A (2003) Alcohol promotes dopamine release in the human nucleus accumbens. Synapse 49:226\u2013231","journal-title":"Synapse"},{"key":"3915_CR6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/npp.2008.138","volume":"34","author":"MG Bossong","year":"2009","unstructured":"Bossong MG, van Berckel BN, Boellaard R, Zuurman L, Schuit RC, Windhorst AD, van Gerven JMA, Ramsey NF, Lammertsma AA, Kahn RS (2009) Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology 34:759\u2013766","journal-title":"Neuropsychopharmacology"},{"key":"3915_CR7","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1073\/pnas.94.6.2569","volume":"94","author":"A Breier","year":"1997","unstructured":"Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, De Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D (1997) Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A 94:2569\u20132574","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3915_CR8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/npp.2008.87","volume":"34","author":"AL Brody","year":"2009","unstructured":"Brody AL, Mandelkern MA, Olmstead RE, Allen-Martinez Z, Scheibal D, Abrams AL, Costello MR, Farahi J, Saxena S, Monterosso J, London ED (2009) Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette. Neuropsychopharmacology 34:282\u2013289","journal-title":"Neuropsychopharmacology"},{"key":"3915_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/syn.10282","volume":"51","author":"L Cardenas","year":"2004","unstructured":"Cardenas L, Houle S, Kapur S, Busto UE (2004) Oral D-amphetamine causes prolonged displacement of [11C]raclopride as measured by PET. Synapse 51:27\u201331","journal-title":"Synapse"},{"key":"3915_CR10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00004647-199704000-00009","volume":"17","author":"RE Carson","year":"1997","unstructured":"Carson RE, Breier A, de Bartolomeis A, Saunders RC, Su TP, Schmall B, Der MG, Pickar D, Eckelman WC (1997) Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion. J Cereb Blood Flow Metab 17:437\u2013447","journal-title":"J Cereb Blood Flow Metab"},{"key":"3915_CR11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF02245916","volume":"102","author":"JP Chen","year":"1990","unstructured":"Chen JP, Paredes W, Li J, Smith D, Lowinson J, Gardner EL (1990) Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology (Berl) 102:156\u2013162","journal-title":"Psychopharmacology (Berl)"},{"key":"3915_CR12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00213-007-1042-2","volume":"198","author":"DC D\u2019Souza","year":"2008","unstructured":"D\u2019Souza DC, Braley G, Blaise R, Vendetti M, Oliver S, Pittman B, Ranganathan M, Bhakta S, Zimolo Z, Cooper T, Perry E (2008) Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans. Psychopharmacology (Berl) 198:587\u2013603","journal-title":"Psychopharmacology (Berl)"},{"key":"3915_CR13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pnpbp.2011.12.005","volume":"38","author":"MA Khoury El","year":"2012","unstructured":"El Khoury MA, Gorgievski V, Moutsimilli L, Giros B, Tzavara ET (2012) Interactions between the cannabinoid and dopaminergic systems: evidence from animal studies. Prog Neuropsychopharmacol Biol Psychiatry 38:36\u201350","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3915_CR14","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1097\/01.wnr.0000236853.40221.8e","volume":"17","author":"P Fadda","year":"2006","unstructured":"Fadda P, Scherma M, Spano MS, Salis P, Melis V, Fattore L, Fratta W (2006) Cannabinoid self-administration increases dopamine release in the nucleus accumbens. Neuroreport 17:1629\u20131632","journal-title":"Neuroreport"},{"key":"3915_CR15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0304-3940(97)00278-4","volume":"226","author":"ED French","year":"1997","unstructured":"French ED (1997) Delta9-tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neurosci Lett 226:159\u2013162","journal-title":"Neurosci Lett"},{"key":"3915_CR16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00001756-199702100-00014","volume":"8","author":"ED French","year":"1997","unstructured":"French ED, Dillon K, Wu X (1997) Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. Neuroreport 8:649\u2013652","journal-title":"Neuroreport"},{"key":"3915_CR17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pbb.2005.01.032","volume":"81","author":"EL Gardner","year":"2005","unstructured":"Gardner EL (2005) Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol Biochem Behav 81:263\u2013284","journal-title":"Pharmacol Biochem Behav"},{"key":"3915_CR18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(97)01442-8","volume":"341","author":"GL Gessa","year":"1998","unstructured":"Gessa GL, Melis M, Muntoni AL, Diana M (1998) Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur J Pharmacol 341:39\u201344","journal-title":"Eur J Pharmacol"},{"key":"3915_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/bjp.bp.113.138578","volume":"205","author":"OD Howes","year":"2014","unstructured":"Howes OD, Kapur S (2014) A neurobiological hypothesis for the classification of schizophrenia: type A (hyperdopaminergic) and type B (normodopaminergic). Br J Psychiatry 205:1\u20133","journal-title":"Br J Psychiatry"},{"key":"3915_CR20","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533\u20131539","journal-title":"J Cereb Blood Flow Metab"},{"key":"3915_CR21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00004647-199601000-00005","volume":"16","author":"AA Lammertsma","year":"1996","unstructured":"Lammertsma AA, Bench CJ, Hume SP, Osman S, Gunn K, Brooks DJ, Frackowiak RS (1996) Comparison of methods for analysis of clinical [11C]raclopride studies. J Cereb Blood Flow Metab 16:42\u201352","journal-title":"J Cereb Blood Flow Metab"},{"key":"3915_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-2396(199701)25:1<1::AID-SYN1>3.0.CO;2-H","volume":"25","author":"M Laruelle","year":"1997","unstructured":"Laruelle M, Iyer RN, Al-Tikriti MS, Zea-Ponce Y, Malison R, Zoghbi SS, Baldwin RM, Kung HF, Charney DS, Hoffer PB, Innis RB, Bradberry CW (1997) Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. Synapse 25:1\u201314","journal-title":"Synapse"},{"key":"3915_CR23","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1177\/0269881109358200","volume":"24","author":"M Liem-Moolenaar","year":"2010","unstructured":"Liem-Moolenaar M, te Beek ET, de Kam ML, Franson KL, Kahn RS, Hijman R, Touw D, van Gerven JMA (2010) Central nervous system effects of haloperidol on THC in healthy male volunteers. J Psychopharmacol 24:1697\u20131708","journal-title":"J Psychopharmacol"},{"key":"3915_CR24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.bjp.0702753","volume":"128","author":"DT Malone","year":"1999","unstructured":"Malone DT, Taylor DA (1999) Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats. Br J Pharmacol 128:21\u201326","journal-title":"Br J Pharmacol"},{"key":"3915_CR25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00004647-200303000-00004","volume":"23","author":"D Martinez","year":"2003","unstructured":"Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, Huang Y, Cooper T, Kegeles L, Zarahn E, Abi-Dargham A, Haber SN, Laruelle M (2003) Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 23:285\u2013300","journal-title":"J Cereb Blood Flow Metab"},{"key":"3915_CR26","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1176\/appi.ajp.164.4.622","volume":"164","author":"D Martinez","year":"2007","unstructured":"Martinez D, Narendran R, Foltin RW, Slifstein M, Hwang DR, Broft A, Huang Y, Cooper TB, Fischman MW, Kleber HD, Laruelle M (2007) Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am J Psychiatry 164:622\u2013629","journal-title":"Am J Psychiatry"},{"key":"3915_CR27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","volume":"370","author":"TH Moore","year":"2007","unstructured":"Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370:319\u2013328","journal-title":"Lancet"},{"key":"3915_CR28","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nn1737","volume":"9","author":"MA Nader","year":"2006","unstructured":"Nader MA, Morgan D, Gage HD, Nader SH, Calhoun TL, Buchheimer N, Ehrenkaufer R, Mach RH (2006) PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat Neuroscience 9:1050\u20131056","journal-title":"Nat Neuroscience"},{"key":"3915_CR29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0006-8993(88)90749-4","volume":"451","author":"JM Ng Cheong Ton","year":"1988","unstructured":"Ng Cheong Ton JM, Gerhardt GA, Friedemann M, Etgen AM, Rose GM, Sharpless NS, Gardner EL (1988) The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study. Brain Res 451:59\u201368","journal-title":"Brain Res"},{"key":"3915_CR30","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/sj.npp.1300667","volume":"30","author":"LM Oswald","year":"2005","unstructured":"Oswald LM, Wong DF, McCaul M, Zhou Y, Kuwabara H, Choi L, Brasic J, Wand GS (2005) Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine. Neuropsychopharmacology 30:821\u2013832","journal-title":"Neuropsychopharmacology"},{"key":"3915_CR31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00213-008-1075-1","volume":"197","author":"S Sevy","year":"2008","unstructured":"Sevy S, Smith GS, Ma Y, Dhawan V, Chaly T, Kingsley PB, Kumra S, Abdelmessih S, Eidelberg D (2008) Cerebral glucose metabolism and D2\/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography. Psychopharmacology (Berl) 197:549\u201356","journal-title":"Psychopharmacology (Berl)"},{"key":"3915_CR32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuroimage.2009.06.029","volume":"48","author":"PR Stokes","year":"2009","unstructured":"Stokes PR, Mehta MA, Curran HV, Breen G, Grasby PM (2009) Can recreational doses of THC produce significant dopamine release in the human striatum? Neuroimage 48:186\u2013190","journal-title":"Neuroimage"},{"key":"3915_CR33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/0269881111414090","volume":"26","author":"PR Stokes","year":"2012","unstructured":"Stokes PR, Egerton A, Watson B, Reid A, Lappin J, Howes OD, Nutt DJ, Lingford-Hughes AR (2012) History of cannabis use is not associated with alterations in striatal dopamine D2\/D3 receptor availability. J Psychopharmacol 26:144\u2013149","journal-title":"J Psychopharmacol"},{"key":"3915_CR34","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/0269881108089870","volume":"22","author":"A Strougo","year":"2008","unstructured":"Strougo A, Zuurman L, Roy C, Pinquier JL, van Gerven JM, Cohen AF, Schoemaker RC (2008) Modelling of the concentration-effect relationship of THC on central nervous system parameters and heart rate\u2014insight into its mechanisms of action and a tool for clinical research and development of cannabinoids. J Psychopharmacol 22:717\u2013726","journal-title":"J Psychopharmacol"},{"key":"3915_CR35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0091-3057(97)00422-X","volume":"59","author":"E Sulcova","year":"1998","unstructured":"Sulcova E, Mechoulam R, Fride E (1998) Biphasic effects of anandamide. Pharmacol Biochem Behav 59:347\u2013352","journal-title":"Pharmacol Biochem Behav"},{"key":"3915_CR36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1017\/S1461145707008103","volume":"11","author":"H Takahashi","year":"2008","unstructured":"Takahashi H, Fujimura Y, Hayashi M, Takano H, Kato M, Okubo Y, Kanno I, Ito H, Suhara T (2008) Enhanced dopamine release by nicotine in cigarette smokers: a double-blind, randomized, placebo-controlled pilot study. Int J Neuropsychopharmacol 11:413\u2013417","journal-title":"Int J Neuropsychopharmacol"},{"key":"3915_CR37","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1126\/science.276.5321.2048","volume":"276","author":"G Tanda","year":"1997","unstructured":"Tanda G, Pontieri FE, Di Chiara G (1997) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276:2048\u20132050","journal-title":"Science"},{"key":"3915_CR38","first-page":"166","volume-title":"An Introduction to error analysis","author":"JR Taylor","year":"1997","unstructured":"Taylor JR (1997) An Introduction to error analysis, 2nd edn. University Science Books, Sausalito, California, pp 166\u2013168","edition":"2"},{"key":"3915_CR39","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.biopsych.2010.06.005","volume":"68","author":"NB Urban","year":"2010","unstructured":"Urban NB, Kegeles LS, Slifstein M, Xu X, Martinez D, Sakr E, Castillo F, Moadel T, O\u2019Malley SS, Krystal JH, Abi-Dargham A (2010) Sex differences in striatal dopamine release in young adults after oral alcohol challenge: a positron emission tomography imaging study with [11C]raclopride. Biol Psychiatry 68:689\u2013696","journal-title":"Biol Psychiatry"},{"key":"3915_CR40","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.biopsych.2011.12.018","volume":"71","author":"NB Urban","year":"2012","unstructured":"Urban NB, Slifstein M, Thompson JL, Xu X, Girgis RR, Raheja S, Haney M, Abi-Dargham A (2012) Dopamine release in chronic cannabis users: a [11C]raclopride positron emission tomography study. Biol Psychiatry 71:677\u2013683","journal-title":"Biol Psychiatry"},{"key":"3915_CR41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.mp.4001507","volume":"9","author":"ND Volkow","year":"2004","unstructured":"Volkow ND, Fowler JS, Wang GJ, Swanson JM (2004) Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry 9:557\u2013569","journal-title":"Mol Psychiatry"},{"key":"3915_CR42","doi-asserted-by":"crossref","first-page":"15037","DOI":"10.1073\/pnas.1010654108","volume":"108","author":"ND Volkow","year":"2011","unstructured":"Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F (2011) Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci U S A 108:15037\u201315042","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3915_CR43","doi-asserted-by":"crossref","first-page":"E3149","DOI":"10.1073\/pnas.1411228111","volume":"111","author":"ND Volkow","year":"2014","unstructured":"Volkow ND, Wang GJ, Telang F, Fowler JS, Alexoff D, Logan J, Jayne M, Wong C, Tomasi D (2014) Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity. Proc Natl Acad Sci U S A 111:E3149\u2013E3156","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3915_CR44","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1038\/sj.npp.1301373","volume":"32","author":"GS Wand","year":"2007","unstructured":"Wand GS, Oswald LM, McCaul ME, Wong DF, Johnson E, Zhou Y, Kuwabara H, Kumar A (2007) Association of amphetamine-induced striatal dopamine release and cortisol responses to psychological stress. Neuropsychopharmacology 32:2310\u20132320","journal-title":"Neuropsychopharmacology"},{"key":"3915_CR45","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.tins.2009.06.004","volume":"32","author":"RA Wise","year":"2009","unstructured":"Wise RA (2009) Roles for nigrostriatal\u2014not just mesocorticolimbic\u2014dopamine in reward and addiction. Trends Neurosci 32:517\u2013524","journal-title":"Trends Neurosci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-015-3915-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-015-3915-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-015-3915-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T13:23:30Z","timestamp":1747833810000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-015-3915-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,25]]},"references-count":45,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["3915"],"URL":"https:\/\/doi.org\/10.1007\/s00213-015-3915-0","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,25]]}}}